Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $13.6 million.

  • Biote's Free Cash Flow fell 309.15% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.4 million, marking a year-over-year increase of 140.67%. This contributed to the annual value of $38.8 million for FY2024, which is 5823.31% up from last year.
  • Latest data reveals that Biote reported Free Cash Flow of $13.6 million as of Q3 2025, which was down 309.15% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Biote's Free Cash Flow peaked at $17.9 million during Q2 2021, and registered a low of -$29.1 million during Q2 2022.
  • Over the past 5 years, Biote's median Free Cash Flow value was $6.0 million (recorded in 2022), while the average stood at $5.7 million.
  • As far as peak fluctuations go, Biote's Free Cash Flow crashed by 26222.35% in 2022, and later surged by 1092834.65% in 2024.
  • Over the past 5 years, Biote's Free Cash Flow (Quarter) stood at $9.7 million in 2021, then tumbled by 40.82% to $5.7 million in 2022, then rose by 0.84% to $5.8 million in 2023, then soared by 84.67% to $10.7 million in 2024, then grew by 26.87% to $13.6 million in 2025.
  • Its Free Cash Flow stands at $13.6 million for Q3 2025, versus $5.3 million for Q2 2025 and $4.8 million for Q1 2025.